67 results
8-K
ATXI
Avenue Therapeutics Inc
26 Apr 24
Avenue Therapeutics Announces Reverse Stock Split
4:39pm
and reclassified as one share of Common Stock. Proportionate voting rights and other rights of common stockholders will not be affected by the reverse
424B3
ATXI
Avenue Therapeutics Inc
2 Feb 24
Prospectus supplement
12:00am
outstanding held by 31 record stockholders.
Common Stock
Voting Rights
Holders of our Common Stock are entitled to one vote for each share held on all … matters submitted to a vote of stockholders and do not have cumulative voting rights. An election of directors by our stockholders shall
DEF 14C
ATXI
Avenue Therapeutics Inc
29 Jan 24
Information statement
8:00am
securities convertible into Common Stock in the future, it could dilute the voting rights of existing stockholders and could also dilute earnings per … ownership or voting rights of persons seeking to obtain control without our agreement. Similarly, the issuance of additional shares to certain
PRE 14C
h683nnk v3eiw3z
17 Jan 24
Preliminary information
5:05pm
8-K
EX-4.2
g43v4o3ql5ut9
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.1
kspqih4lbvy42
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
drt7cz1 5zsgtv
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.2
10cbam j2oumvt3
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.1
qbs a0vecxx7do0a3
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.3
0ig7quy2xrpn1bc zdo
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
tux9 s47oyjpg
2 Nov 23
Prospectus supplement with pricing info
9:00am
424B3
jsehkdyuccm82se6w
28 Jun 23
Prospectus supplement
4:56pm